Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > FAILURES by Dr. Bokhari and the Board
View:
Post by junjun26 on Apr 02, 2021 9:27am

FAILURES by Dr. Bokhari and the Board

Actually, In November 2020, as the price of the Shares approached new lows, Messrs. Durkacz and Saeed, founding directors of the Company and two of the Concerned Shareholders, spoke to Dr. Bokhari, about this lack of progress and identified what they believed was a promising strategic acquisition opportunity.

Comment by junjun26 on Apr 02, 2021 9:28am
They were disappointed that Dr. Bokahari showed no interest in considering the opportunity and, in December 2020, sought to have the Board reconsider Dr. Bokhari’s position.
Comment by junjun26 on Apr 02, 2021 9:30am
Dr. Bokhari has also used his position as the Company’s Chief Executive Officer to take direct actions against individual Concerned Shareholders. These improper punitive actions have exposed the Company to unnecessary legal claims.
Comment by junjun26 on Apr 02, 2021 9:36am
Shockingly, this is not the only example of Dr. Bokhari abusing the power of his role to silence opposition to his conduct. Mr. Saeed, a Concerned Shareholder, is a co-founder of FSD. On December 23, 2020, the Company’s legal counsel wrote to him advising that a special committee of the Board was conducting an investigation into certain employment-related matters involving Mr. Saeed.
Comment by junjun26 on Apr 02, 2021 9:37am
Under oath during cross-examination, Dr. Bokhari has since acknowledged that there was no such special committee and that this was merely an independent action undertaken by him to attack Mr. Saeed for “insubordination” in the face of his challenges to the Company’s management
Comment by Mil_Man54 on Apr 02, 2021 9:39am
Looks like junjun26 is one of realization's other accounts
Comment by junjun26 on Apr 02, 2021 9:41am
People who have much time criticising others that is Mil_Man54.
Comment by junjun26 on Apr 02, 2021 9:49am
And then Failed to address the dramatic loss of Shareholder value, with the Class B Shares trading over 97% lower than when Dr. Bokhari was appointed Interim Chief Executive Office
Comment by Mil_Man54 on Apr 02, 2021 9:54am
Blah....blah....blah.....give it up pumper
Comment by junjun26 on Apr 02, 2021 10:00am
Failed to effectively implement the Company’s business plan to become a pharmaceutical and biotechnology company, having to date failed to meet any of their modest stated goals.
Comment by Mil_Man54 on Apr 02, 2021 10:01am
junjun26.....failed as a pumper....
Comment by junjun26 on Apr 02, 2021 10:02am
Denied Shareholders any say on the change of the Company’s strategic focus, failing to hold a Shareholders’ meeting in 2020 and seeking to delay holding a meeting in 2021.
Comment by junjun26 on Apr 02, 2021 10:03am
Caused FSD to reimburse Dr. Bokhari’s privately owned and controlled company for over $1.4 million of expenses in 2020, with limited transparency or explanation.
Comment by Mil_Man54 on Apr 02, 2021 10:31am
Comment by mhaimillionaire on Apr 09, 2021 2:14pm
The Company had not held an annual meeting of Shareholders since December 2019, prior to the change in business strategy, and it was time for the Shareholders to have a chance to vote on FSD’s future. The Board (other than Messrs. Durkacz and Saeed) delayed considering the Requisition for several weeks before responding by scheduling a meeting to be held on June 29, 2021, nearly six months after ...more  
Comment by Mil_Man54 on Apr 09, 2021 3:32pm
Finally....I thought this pumper would never leave.....please ignore EVERYTHING this ulti-account pumper posts....it's self serving BS and only half the picture.....do your own DD outside of this board and make informed decisions about your investments!
Comment by junjun26 on Apr 02, 2021 12:36pm
As requested by the Concerned Shareholders, the Court also ordered that Dr. Bokhari not act as chair of the Meeting. Instead, an independent person will be appointed to ensure that the Meeting is run in a fair and orderly fashion.
Comment by junjun26 on Apr 02, 2021 2:32pm
FYI..Dr.Bokhari and the other 2 boards failed to address the dramatic loss of Shareholder value, with the Class B Shares trading over 97% lower than when Dr. Bokhari was appointed Interim Chief Executive Officer.
Comment by junjun26 on Apr 02, 2021 2:34pm
There is a really big loss to the Company’s market capitalization which is shrunk since Dr.Bokhari was appointed Interim Chief Executive Officer on. October 29, 2018.
Comment by junjun26 on Apr 02, 2021 3:09pm
The Concerned Shareholders have identified many actions by Dr. Raza Bokhari and other board members, Stephen Buyer, Robert Ciaruffoli, James Datin, Gerald Goldberg and Larry Kaiser, that have harmed shareholders.
Comment by junjun26 on Apr 02, 2021 3:09pm
During this time, Dr. Raza Bokhari, Stephen Buyer, Robert Ciaruffoli, James Datin, Gerald Goldberg and Larry Kaiser, have lined their pockets by awarding themselves cash and Class B shares for services yet to be provided
Comment by Boni94 on Apr 02, 2021 3:10pm
 That’s why it is really frustrating knowing what they did.
Comment by Boni94 on Apr 02, 2021 3:12pm
So the Concerned Shareholders are extremely pleased that these highly qualified individuals have stepped forward to help restore FSD.
Comment by Mil_Man54 on Apr 02, 2021 6:40pm
That's right....step forward and up to that FSD trough and get your fill of that hard earned investor's money
Comment by mhaimillionaire on Apr 09, 2021 2:10pm
This post has been removed in accordance with Community Policy
Comment by mhaimillionaire on Apr 09, 2021 2:08pm
This has  been well documented in the past.
Comment by mhaimillionaire on Apr 09, 2021 2:07pm
The facts are, that Durcaz did through investment banking with First Republic bring FSD to the market.  For this they received a significant payment, the size od which as questioned independentlty .  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities